This comment is to urgently oppose new regulations on so-called "complex products." As an investor with over a decade of experience, I am neither a professional, nor a novice. But the notion of regulating leveraged and inverse products is nonsensical. These products are far and away the easiest to understand of any ETFs/ETNs available to retail investors.
A "complex product" is really just picking a market direction and pace. That's it.
On the flip side, trying to understand the fundamental and technical metrics that value a company is a far more complex endeavor.
Veteran investment professionals with high-level training and experience can and do debate whether or not a stock is a "buy" or a "sell". The complexities going into that analysis can be much more subjective compared to whether you believe the market will, in general, go up or down.
Do not take away inverse products. Investors will be replace their use with options and short selling, which are far more complex and risky.
You either have to let investors take inherent risk, or prohibit everybody from access to the stock market. Which would be an egregious overreach.
Please stick to preventing companies from unfairly and unexpectedly redeeming shares. That is the true problem with retail investing and seems to escape the attention of FINRA.
For the Public
FINRA DATA
FINRA Data provides non-commercial use of data, specifically the ability to save data views and create and manage a Bond Watchlist.
For Industry Professionals
FINPRO
Registered representatives can fulfill Continuing Education requirements, view their industry CRD record and perform other compliance tasks.
For Member Firms
FINRA GATEWAY
Firm compliance professionals can access filings and requests, run reports and submit support tickets.
For Case Participants
DR PORTAL
Arbitration and mediation case participants and FINRA neutrals can view case information and submit documents through this Dispute Resolution Portal.
Need Help? | Check System Status
Log In to other FINRA systems
Jason Munoz Comment On Regulatory Notice 22-08
This comment is to urgently oppose new regulations on so-called "complex products." As an investor with over a decade of experience, I am neither a professional, nor a novice. But the notion of regulating leveraged and inverse products is nonsensical. These products are far and away the easiest to understand of any ETFs/ETNs available to retail investors.
A "complex product" is really just picking a market direction and pace. That's it.
On the flip side, trying to understand the fundamental and technical metrics that value a company is a far more complex endeavor.
Veteran investment professionals with high-level training and experience can and do debate whether or not a stock is a "buy" or a "sell". The complexities going into that analysis can be much more subjective compared to whether you believe the market will, in general, go up or down.
Do not take away inverse products. Investors will be replace their use with options and short selling, which are far more complex and risky.
You either have to let investors take inherent risk, or prohibit everybody from access to the stock market. Which would be an egregious overreach.
Please stick to preventing companies from unfairly and unexpectedly redeeming shares. That is the true problem with retail investing and seems to escape the attention of FINRA.